Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients

Summary

M5181 - a novel vitamin D3 analogue - is currently under development for the treatment of plaque psoriasis and is being developed as a topical ointment formulation (M518101) Clinical and non-clinical studies indicate that M5181 is an effective treatment for plaque psoriasis. Based on the results of previous phase II trials the phase III trial has been designed to evaluate efficacy and safety of an 8-week treatment period with 50 μg/g M518101 in a larger population of patients with stable plaque psoriasis.

Timeline

Start

2013-10

Primary completion

2014-12

Completion

2014-12

Drugs

Indications